JAMA : the journal of the American Medical Association
-
Bipolar disorder affects approximately 8 million adults in the US and approximately 40 million individuals worldwide. ⋯ Bipolar disorder affects approximately 8 million adults in the US. First-line therapy includes mood stabilizers, such as lithium, anticonvulsants, such as valproate and lamotrigine, and atypical antipsychotic drugs, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine.